同: 頚膨大

WordNet

relating to or associated with the neck
of or relating to the cervix of the uterus; "cervical cancer"
the state of being enlarged
a photographic print that has been enlarged (同)blowup, magnification

PrepTutorEJDIC

(子宮などの)頚(けい)部の(にできた)
〈U〉〈C〉拡大,増大,拡張;増補;増築 / 〈C〉拡大(増大,拡張)された部分 / 〈C〉(写真)の引き伸ばし;引き伸ばした写真

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2015/10/28 22:23:11」(JST)

wiki en

[Wiki en表示]

The cervical enlargement corresponds with the attachments of the large nerves which supply the upper limbs.

It extends from about the third cervical to the second thoracic vertebra, its maximum circumference (about 38 mm.) being on a level with the attachment of the sixth pair of cervical nerves.

The reason behind the enlargement of the cervical region is because of the increased neural input and output to the upper limbs.

An analogous region in the lower limbs occurs at the lumbar enlargement.

References

This article incorporates text in the public domain from the 20th edition of Gray's Anatomy (1918)

External links

lesson6spinalcord&coverings at The Anatomy Lesson by Wesley Norman (Georgetown University)
Anatomy photo:02:08-0101 at the SUNY Downstate Medical Center - "Vertebral Canal and Spinal Cord: Regions of the Spinal Cord"
Atlas image: n3a5p3 at the University of Michigan Health System - "Spinal Cord, Fetus, Posterior View"

This neuroscience article is a stub. You can help Wikipedia by expanding it.

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 小児における咽喉痛の評価 evaluation of sore throat in children
2. 頚管妊娠 cervical pregnancy
3. 小児における末梢のリンパ節腫脹 peripheral lymphadenopathy in children etiology
4. 子宮頸部の先天性奇形および子宮頸部良性病変 congenital cervical anomalies and benign cervical lesions
5. 成人における末梢リンパ節腫大の評価 evaluation of peripheral lymphadenopathy in adults

English Journal

TMCO1 deficiency causes autosomal recessive cerebrofaciothoracic dysplasia.

Alanay Y, Ergüner B, Utine E, Haçarız O, Kiper PO, Taşkıran EZ, Perçin F, Uz E, Sağıroğlu MŞ, Yuksel B, Boduroglu K, Akarsu NA.Author information Department of Pediatrics, Pediatric Genetics, Hacettepe University Medical Faculty, Ankara, Turkey; Department of Pediatrics, Pediatric Genetics, Acıbadem University Medical Faculty, Istanbul, Turkey.AbstractCerebrofaciothoracic dysplasia (CFT) (OMIM #213980) is a multiple congenital anomaly and intellectual disability syndrome involving the cranium, face, and thorax. The characteristic features are cranial involvement with macrocrania at birth, brachycephaly, various CT/MRI findings including hypoplasia of corpus callosum, enlargement of septum pellicidum, and diffuse hypodensity of the grey matter, flat face, hypertelorism, cleft lip and cleft palate, low-set, posteriorly rotated ears, short neck, and multiple costal and vertebral anomalies. The underlying genetic defect remains unknown. Using combination of homozygosity mapping and whole-exome sequencing, we identified a homozygous nonsense founder mutation, p.Arg87Ter (c.259 C>T), in the human transmembrane and coiled-coil domains protein 1 (TMCO1) in four out of five families of Turkish origin. The entire critical region on chromosome 1q24 containing TMCO1 was excluded in the fifth family with characteristic findings of CFT providing evidence for genetic heterogeneity of CFT spectrum. Another founder TMCO1 mutation has recently been reported to cause a unique genetic condition, TMCO1-defect syndrome (OMIM #614132). TMCO1-defect syndrome shares many features with CFT. This study supports the fact that "TMCO1-defect syndrome," initially thought to represent a distinct disorder, indeed belongs to the genetically heterogeneous CFT dysplasia spectrum. © 2013 Wiley Periodicals, Inc.
American journal of medical genetics. Part A.Am J Med Genet A.2014 Feb;164(2):291-304. doi: 10.1002/ajmg.a.36248. Epub 2013 Nov 5.
Cerebrofaciothoracic dysplasia (CFT) (OMIM #213980) is a multiple congenital anomaly and intellectual disability syndrome involving the cranium, face, and thorax. The characteristic features are cranial involvement with macrocrania at birth, brachycephaly, various CT/MRI findings including hypoplasi
PMID 24194475

Management of persistent tracheoesophageal puncture.

Mobashir MK, Basha WM, Mohamed AE, Anany AM.Author information Department of Oto-Rhino-Laryngology and Head and Neck Surgery, Faculty of Medicine, Zagazig University, Zagazig, Egypt, mobashir555@hotmail.com.AbstractTracheoesophageal puncture with placement of a voice prosthesis (VP) provides successful speech rehabilitation after total laryngectomy. However, enlargement of the tracheoesophageal puncture is a challenging complication as it results in leakage around the VP into the airway and may eventually lead to aspiration pneumonia and respiratory complications. It necessitates removal of the VP and permanent closure of the tracheoesophageal fistula. We present our own experience for surgical closure of persistent tracheoesophageal puncture. A non-controlled prospective study was conducted at the Department of Oto-Rhino-Laryngology and Head and Neck Surgery, Zagazig University Hospitals, Zagazig, Egypt. This study included five patients with an enlarged tracheoesophageal puncture. They had persistent leakage around the VP with resulting recurrent chest infections. None of the patients underwent previous surgical intervention for closure of the tracheoesophageal fistula. This surgical technique involved identification and exposure of the tracheoesophageal fistula tract by blunt dissection and its ligation by non-resorbable sutures at two points close to the posterior wall of the trachea without dividing the fistula tract. The mean follow-up period was 14.4 months. Successful closure of the fistula was achieved in all patients (100 %). All patients tolerated full diet well and had uneventful recovery and no further episodes of aspiration. This surgical technique is simple, easily feasible technically, and effective. It enables early oral feeding and allows a short hospital stay, thus increasing the patient's comfort.
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery.Eur Arch Otorhinolaryngol.2014 Feb;271(2):379-83. doi: 10.1007/s00405-013-2515-z. Epub 2013 May 5.
Tracheoesophageal puncture with placement of a voice prosthesis (VP) provides successful speech rehabilitation after total laryngectomy. However, enlargement of the tracheoesophageal puncture is a challenging complication as it results in leakage around the VP into the airway and may eventually lead
PMID 23644996

INCRAFT® Stent-Graft System: one-year outcome of the INNOVATION Trial.

Coppi G, Njila M, Coppi G, Saitta G, Silingardi R, Pratesi C, Chiesa R, Scheinert D, Brunkwall JS, Torsello G.Author information Department of Vascular Surgery Nuovo Ospedale Civile S. Agostino-Estense Baggiovara University of Modena and Reggio Emilia Baggiovara, Modena, Italy - gioachino.coppi@unimore.it.AbstractAim: Endovascular repair has surpassed open surgical treatment as the most common procedure in patients with abdominal aortic aneurysms (AAA), yet its applicability remains limited to those with aortoiliac anatomy suitable for the introduction and deployment of the devices. The current study was performed to assess the safety and efficacy of INCRAFT® (Cordis Corporation, Bridgewater, NJ), an ultra-low-profile device for the treatment of AAA. Methods: The INNOVATION study is a first in human prospective, multicenter trial involving 6 centers in Europe. From March 2010 to June 2011 60 patients with asymptomatic AAA were treated with the INCRAFT® bifurcated Stent-Graft System. The main inclusion criteria were a proximal aortic neck of 15 mm or more in length and up to 27 mm in diameter; iliac landing zones greater than 10 mm in length and between 9 and 18 mm in diameter; an access vessel large enough to accept the 14F outer diameter of the delivery system; and an aortic bifurcation >18 mm in diameter. The primary endpoint was technical success at one-month; one-year safety endpoints included the absence of device- or procedure-related major adverse events; absence of type I or III endoleaks; and maintenance of device integrity through one year of follow-up. Results: Among 60 patients treated at six centers, the primary endpoint was met in 56 of 58 patients (97%; 95% CI, 88-100%) who came back for one month follow-up, two patients did not come back for their one month follow-up assessments but remained enrolled in the study. Fifty-six had one-year follow-up data showing 100% freedom from aneurysm enlargement with absence of type I and III endoleaks in all patients. There were two patients (3.6%) with a type Ia endoleak which was successfully treated with secondary endovascular intervention in both occasions. Core laboratory evaluation of the postoperative imaging studies documented absence of endograft migration, stent fracture, or limb occlusion. A single patient (1.8%) died within one year due to sepsis unrelated to the AAA. Conclusion: The results of the INNOVATION study with the INCRAFT® Stent-Graft are encouraging, with satisfactory clinical outcome and device durability through one-year of follow-up. The INCRAFT® device is a novel ultra-low-profile endograft that holds promise to broaden the patient population eligible for endovascular aneurysm repair.
The Journal of cardiovascular surgery.J Cardiovasc Surg (Torino).2014 Feb;55(1):51-9.
Aim: Endovascular repair has surpassed open surgical treatment as the most common procedure in patients with abdominal aortic aneurysms (AAA), yet its applicability remains limited to those with aortoiliac anatomy suitable for the introduction and deployment of the devices. The current study was per
PMID 24356046

Japanese Journal

鑑別に注意を要した両側頸部多発リンパ節腫脹の2例

篠崎泰久,神部芳則,伊藤弘人,野口忠秀,草間幹夫,小林馨
歯科放射線 51(1), 27-28, 2011-12-31
NAID 10030283169

Cervical Unilateral Open-Door Laminoplasty With Titanium Miniplates Through Newly Designed Hydroxyapatite Spacers : Technical Note

TANAKA Satoshi,TASHIRO Takashi,GOMI Akira,UJIIE Hiroshi
Neurologia medico-chirurgica = 神経外科 51(9), 673-677, 2011-09-15
… A newly designed hydroxyapatite (HA) spacer for cervical laminoplasty is provided with a hole through which the titanium miniplate is passed. … Twenty-two patients with cervical stenotic disorders were treated by this procedure. … Mean enlargement of the minimum spinal canal diameter was 50.9%. …
NAID 10029458311

「頚膨大」

Cervical enlargement
	Diagrams of the medulla spinalis. (Cervical enlargement labeled at upper right.)
Details
Latin	intumescentia cervicalis
Identifiers
Gray's	p.752
Dorlands; /Elsevier	i_11/12457947
TA	A14.1.02.002
FMA	74893
	Anatomical terminology